About Xiyuan hospital, China Academy of Chinese Medical Sciences
Clinical Trials at Xiyuan hospital, China Academy of Chinese Medical Sciences
During the past decade, Xiyuan hospital, China Academy of Chinese Medical Sciences conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Xiyuan hospital, China Academy of Chinese Medical Sciences" #1 sponsor was "Xiyuan Hospital of China Academy of Chinese Medical Sciences" with 9 trials, followed by "Beijing University of Chinese Medicine" with 2 trials
sponsored, "Jie Li" with 2 trials sponsored, "Acotec Scientific Co., Ltd" with 1 trials sponsored and "Biotyx Medical (Shenzhen) Co., Ltd."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Xiyuan hospital, China Academy of Chinese Medical Sciences"
#1 collaborator was "Xiyuan Hospital of China Academy of Chinese Medical Sciences" with 2 trials as a collaborator, "Dongzhimen Hospital, Beijing" with 1 trials as a collaborator, "First Teaching Hospital of Tianjin University of Traditional Chinese Medicine" with 1 trials as a collaborator, "Guang'anmen Hospital of China Academy of Chinese Medical Sciences" with 1 trials as a collaborator and "Liaoning University of Traditional Chinese Medicine" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Xiyuan hospital, China Academy of Chinese Medical Sciences
According to Clinical.Site data, the most researched conditions in "Xiyuan hospital, China Academy of Chinese Medical Sciences" are
"Chemotherapy-induced Nausea and Vomiting" (2 trials), "Functional Dyspepsia" (2 trials), "Vascular Dementia" (2 trials), "Chronic Stable Angina" (1 trials) and "Critical Limb Ischemia (CLI)" (1 trials). Many other conditions were trialed in "Xiyuan hospital, China Academy of Chinese Medical Sciences" in a lesser frequency.
Clinical Trials Intervention Types at Xiyuan hospital, China Academy of Chinese Medical Sciences
Most popular intervention types in "Xiyuan hospital, China Academy of Chinese Medical Sciences" are "Drug" (14 trials), "Procedure" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Modified Gegen Qinlian Decoction" (2 trials), "Aolanti Weikang tablets" (1 trials), "Chang'an I Recipe" (1 trials) and "DEB catheter" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Xiyuan hospital, China Academy of Chinese Medical Sciences
The vast majority of trials in "Xiyuan hospital, China Academy of Chinese Medical Sciences" are
18 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Xiyuan hospital, China Academy of Chinese Medical Sciences
Currently, there are NaN active trials in "Xiyuan hospital, China Academy of Chinese Medical Sciences".
undefined are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Xiyuan hospital, China Academy of Chinese Medical Sciences,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Xiyuan hospital, China Academy of Chinese Medical Sciences, 3 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 7 trials that are defined as “Not Applicable".